Gregory A Clines1. 1. Division of Endocrinology and Metabolism, University of Virginia, Charlottesville, Virginia 22908-1420, USA. gc4z@virginia.edu
Abstract
PURPOSE OF REVIEW: Bone regeneration and fracture repair are the complex processes of mesenchymal stem cell invasion, chondrogenesis, osteogenesis and angiogenesis. The coordinated actions of these principal processes result in the reconstruction of a normal bone and restoration of a structural unit. However, these normal bone regenerative mechanisms breakdown during fracture repair failure and postmenopausal osteoporosis. RECENT FINDINGS: Recent discoveries of circulating multipotent stem cells with mixed characteristics of endothelial cell and osteogenic capacity have raised interest in new and potentially breakthrough therapies for fracture and pathologic bone loss. The cooperative actions of other mesenchymal stem cell lineage such as adipocytes and processes such as angiogenesis in bone repair could also serve as novel therapeutic targets. Recent data suggest that anabolic parathyroid hormone therapy, already approved for the treatment of osteoporosis, may recruit osteoprogenitor cells and also have a role in fracture repair. SUMMARY: The present review will highlight recent information on stem cells and bone repair and examine potential avenues for future research.
PURPOSE OF REVIEW: Bone regeneration and fracture repair are the complex processes of mesenchymal stem cell invasion, chondrogenesis, osteogenesis and angiogenesis. The coordinated actions of these principal processes result in the reconstruction of a normal bone and restoration of a structural unit. However, these normal bone regenerative mechanisms breakdown during fracture repair failure and postmenopausal osteoporosis. RECENT FINDINGS: Recent discoveries of circulating multipotent stem cells with mixed characteristics of endothelial cell and osteogenic capacity have raised interest in new and potentially breakthrough therapies for fracture and pathologic bone loss. The cooperative actions of other mesenchymal stem cell lineage such as adipocytes and processes such as angiogenesis in bone repair could also serve as novel therapeutic targets. Recent data suggest that anabolic parathyroid hormone therapy, already approved for the treatment of osteoporosis, may recruit osteoprogenitor cells and also have a role in fracture repair. SUMMARY: The present review will highlight recent information on stem cells and bone repair and examine potential avenues for future research.
Authors: Masako Miura; Stan Gronthos; Mingrui Zhao; Bai Lu; Larry W Fisher; Pamela Gehron Robey; Songtao Shi Journal: Proc Natl Acad Sci U S A Date: 2003-04-25 Impact factor: 11.205
Authors: Massimo Dominici; Colin Pritchard; John E Garlits; Ted J Hofmann; Derek A Persons; Edwin M Horwitz Journal: Proc Natl Acad Sci U S A Date: 2004-07-28 Impact factor: 11.205
Authors: J M Gimble; C E Robinson; X Wu; K A Kelly; B R Rodriguez; S A Kliewer; J M Lehmann; D C Morris Journal: Mol Pharmacol Date: 1996-11 Impact factor: 4.436
Authors: B Lanske; A C Karaplis; K Lee; A Luz; A Vortkamp; A Pirro; M Karperien; L H Defize; C Ho; R C Mulligan; A B Abou-Samra; H Jüppner; G V Segre; H M Kronenberg Journal: Science Date: 1996-08-02 Impact factor: 47.728
Authors: Yuko Mori-Akiyama; Haruhiko Akiyama; David H Rowitch; Benoit de Crombrugghe Journal: Proc Natl Acad Sci U S A Date: 2003-07-23 Impact factor: 11.205
Authors: Halil Burç; Tolga Atay; Demir Demirci; Y Barbaros Baykal; Vecihi Kirdemir; Hüseyin Yorgancigil Journal: Indian J Surg Date: 2013-06-09 Impact factor: 0.656
Authors: Jun Li; Li Zhang; Liang Zhou; Zheng-Ping Yu; Feng Qi; Bei Liu; Su-Xia Zi; Li Li; Yi Li; San-Bin Wang; Zheng-Jiang Cui; Xing-Hua Pan Journal: J Transl Med Date: 2012-05-21 Impact factor: 5.531